Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma

1. Ambrogio, C.
2. Gómez-López, G.
3. Falcone, M.
4. Vidal, A.
5. Nadal, E.
6. Crosetto, N.
7. Blasco, R.B.
8. Fernández-Marcos, P.J.
9. Sánchez-Céspedes, M.
10. Ren, X.
11. Wang, Z.
12. Ding, K.
13. Hidalgo, M.
14. Serrano, M.
15. Villanueva, A.
16. Santamaráa, D.
17. Barbacid, M.